Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.
本文公开了可用于治疗有需要的受试者的化合物及其药学上可接受的盐类。本文公开的化合物可以是
酪氨酸和苏
氨酸特异性 cdc2 抑制激酶(Myt1)的
抑制剂。还公开了含有这些化合物或其药学上可接受的盐的药物组合物及其制备和使用方法。